Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation.

被引：0
|
作者：
Misel, M. [1 ,2 ]
Schnickel, G. [1 ]
Berumen, J. [1 ]
Sanchez, R. [3 ]
Mekeel, K. [1 ]
机构：
[1] UC San Diego Hlth, Div Transplant & Hepatobiliary Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Pharm Inpatient Serv, La Jolla, CA USA
[3] UC San Diego Hlth, Anesthesiol, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A241
引用
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [1] Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models
    Ghosh, Subhajit
    Krege, Wilfred
    Doerr, Baerbel
    Mischnik, Marcel
    Pragst, Ingo
    Dickneite, Gerhard
    Herzog, Eva
    PLOS ONE, 2021, 16 (10):
  • [2] Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use
    Uttaro, Elizabeth
    Young, Mikaela R.
    Falvey, Jennifer
    Corvelli, Jenna M.
    Acquisto, Nicole M.
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
  • [3] SAFETY AND EFFICACY OF A FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) PROTOCOL
    Villegas, Skylar
    Gutwald, Taylor
    Wilkinson, Kent
    Finoli, Lauren
    Jenniches, Daniel
    Merkel, Alison
    Reardon, Caitlin
    Young, Sarah
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 405 - 405
  • [4] Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal
    Makhoul, Therese
    Kelly, Gregory
    Kersten, Brian
    Nadler, Megan
    Zammit, Christopher G.
    Jones, Courtney M. C.
    Scott, Rachael
    Acquisto, Nicole M.
    THROMBOSIS RESEARCH, 2020, 194 : 158 - 164
  • [5] Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages
    Barra, Megan E.
    Das, Alvin S.
    Hayes, Bryan D.
    Rosenthal, Eric S.
    Rosovsky, Rachel P.
    Fuh, Lanting
    Patel, Aman B.
    Goldstein, Joshua N.
    Roberts, Russel J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (07) : 1637 - 1647
  • [6] HEALTHCARE RESOURCE UTILIZATION FOR INTRACRANIAL HEMORRHAGE TREATED WITH FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) IN A US HOSPITAL DATABASE
    Mahan, C.
    Wassel, C.
    Gayle, J.
    Dreyfus, J.
    Mcneil-Posey, K.
    Lovelace, B.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 531 - 531
  • [7] Four-Factor Prothrombin Complex Concentrate (4F-PCC) Effectively Reverses Rivaroxaban Induced Bleeding in a Rabbit Model of Acute Bleeding
    Herzog, Eva
    Mueller-Cohrs, Jochen
    Kaspereit, Franz
    Krege, Wilfried
    Niebl, Peter
    Doerr, Baerbel
    Schulte, Stefan
    Dickneite, Gerhard
    BLOOD, 2014, 124 (21)
  • [8] Four-Factor Prothrombin Complex Concentrate (4F-PCC) Is Superior to Three-Factor Prothombin Comlex Concentrates (3F-PCC) for Reversal of Coumarin Anticoagulation
    Herzog, Eva
    Kaspereit, Franz
    Krege, Wilfried
    Niebl, Peter
    Schulte, Stefan
    Dickneite, Gerhard
    BLOOD, 2014, 124 (21)
  • [9] Four-factor Prothrombin Complex Concentrate During Liver Transplantation: A Retrospective Cohort Study
    Lee, Jennifer
    Rivero, Andrea
    Renew, J. Ross
    Spaulding, Aaron
    Borkar, Shalmali
    Mckenzie, Ian
    Davey, Kuki
    Ladlie, Beth
    TRANSPLANTATION DIRECT, 2024, 10 (06):
  • [10] Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
    Melanie N. Smith
    Lindsay Deloney
    Cassandra Carter
    Kyle A. Weant
    Evert A. Eriksson
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 250 - 255
12345